• Lactate Drives HMGB1 Lactylation and Exosomal Release in Sep

  2026-05-29

  This study uncovers how elevated lactate in sepsis triggers macrophage-mediated HMGB1 lactylation and acetylation, promoting its exosomal release and exacerbating vascular permeability. The findings establish a mechanistic link between metabolic dysregulation and inflammatory signaling, suggesting new intervention points for sepsis therapy.

• 3-Deazaneplanocin (DZNep): Reliable Epigenetic Modulation in

  2026-05-29

  This article addresses real-world laboratory challenges in cell viability, proliferation, and cytotoxicity assays, demonstrating how 3-Deazaneplanocin (DZNep) (SKU A1905) enables reproducible, high-sensitivity results. Scenario-driven Q&A blocks guide biomedical researchers through protocol optimization, data interpretation, and informed product selection for robust epigenetic research workflows.

• Distinct GluN2A/B Roles in Trigeminal Sensitization During T

  2026-05-28

  This study elucidates how NMDAR subunits GluN2A and GluN2B differentially regulate connexin and pannexin expression in trigeminal ganglia, advancing understanding of orofacial allodynia mechanisms during temporomandibular joint (TMJ) inflammation. The findings identify discrete signaling pathways and cell–cell communication targets of GluN2A/B, pointing to new therapeutic directions for inflammatory pain.

• Cell lysis buffer for WB and IP: Protease/Phosphatase Protec

  2026-05-28

  Cell lysis buffer for WB and IP enables rapid, non-denaturing protein extraction, integrating a robust protease and phosphatase inhibitor cocktail. This preserves protein integrity and native interactions, making it ideal for Western blot and immunoprecipitation workflows across diverse biological samples.

• Scenario-Driven Solutions with Ridaforolimus (Deforolimus, M

  2026-05-27

  This article addresses reproducibility and workflow challenges in cell-based assays by exploring five real-world scenarios where Ridaforolimus (Deforolimus, MK-8669), SKU B1639, delivers validated solutions. Drawing from peer-reviewed literature and the product dossier, it offers practical guidance for biomedical researchers seeking robust mTOR pathway inhibition in cancer and senescence models.

• Triacetin in Biochemical Research: Protocols, Advantages & T

  2026-05-27

  Triacetin (glyceryl triacetate) stands out as a chemically stable, multi-modal lipid-related reagent for apoptosis induction, metabolic regulation, and ocular formulation development. This guide delivers actionable workflows, troubleshooting insights, and evidence-backed protocol parameters for researchers seeking reproducibility and performance with Triacetin from APExBIO.

• Pexidartinib (PLX3397) in Applied CSF1R Inhibition Workflows

  2026-05-26

  Pexidartinib (PLX3397) enables robust, selective CSF1R-mediated macrophage modulation for translational cancer and neuroinflammation research. This guide delivers practical protocols, troubleshooting strategies, and comparative insight to maximize reproducibility and impact using APExBIO’s trusted reagent.

• PTGER4 Signaling Modulates HDAC4/5/7 and SPINK4 in Rectal Ep

  2026-05-26

  Anbazhagan et al. (2024) elucidate how PTGER4 signaling, driven by stromal cell-derived PGE2, increases class IIa HDAC activity and SPINK4 mRNA in rectal epithelial cells. These findings clarify a mucosal injury response pathway with implications for epithelial homeostasis and inflammatory bowel disease.

• Biotin-16-UTP: Technical Guide for Reliable RNA Labeling

  2026-05-25

  Biotin-16-UTP is a biotin-labeled uridine triphosphate designed for incorporation into RNA during in vitro transcription, enabling downstream RNA detection and purification. It is suited for researchers performing RNA-protein interaction assays, RNA localization studies, and biotin-based RNA purification but is not intended for diagnostic or medical uses. This article details its workflow integration, protocol parameters, and technical boundaries for robust application.

• Fucoidan Modulates Gut–Liver Axis to Mitigate Chemotherapy H

  2026-05-25

  This study uncovers how fucoidan, a sulfated α-L-fucan, alleviates irinotecan-induced steatohepatitis by restoring gut barrier integrity and suppressing inflammatory NETs formation in the liver. These findings establish a mechanistic link between gut–liver axis modulation and chemotherapy-induced liver injury prevention, offering a practical strategy for improving patient outcomes during cancer therapy.

• SAR405: Precision Autophagy Modulation for Translational Imp

  2026-05-24

  Explore how SAR405, a highly selective Vps34 inhibitor, is revolutionizing autophagy research by offering mechanistic clarity, workflow reproducibility, and strategic guidance for translational studies in cancer and neurodegeneration. This thought-leadership article integrates recent paradigm-shifting insights on AMPK-ULK1-Vps34 signaling, positions SAR405 within the competitive landscape, and charts a future-ready roadmap for experimental innovation.

• Ridaforolimus (Deforolimus): mTOR Inhibition and Senescence

  2026-05-23

  Explore Ridaforolimus (Deforolimus) as a selective mTOR inhibitor with advanced applications in cancer research and cellular senescence. This article uniquely bridges molecular mechanism, protocol design, and the latest AI-driven senolytic discovery insights.

• Machine Learning Unlocks New Senolytics for Targeting Senesc

  2026-05-22

  The referenced study presents a novel machine learning framework that identifies potent senolytic compounds by leveraging published data. This approach significantly reduces the cost and time required for early-stage drug discovery, with direct implications for research in cancer, aging, and cell senescence.

• EZ Cap™ mCherry mRNA: Quantitative Redox Sensing & Assay Inn

  2026-05-22

  Discover how mCherry mRNA enables advanced, quantitative redox biosensing, bridging robust fluorescent protein expression with precise metabolic readouts. This article reveals unique assay strategies and scientific insights beyond standard reporter gene applications.

• Leupeptin Hemisulfate Salt: Precision Protease Inhibition in

  2026-05-21

  Explore how Leupeptin hemisulfate salt enables rigorous protease activity regulation for advanced protein degradation studies and epigenetic assay workflows. This article delivers unique insights into optimizing biochemical research protocols with Leupeptin.

15278 records 1/1019 page Next 12345 下5页 Last page